"Pure magic": Jon L. Noble plays World of Warcraft with his thoughts

Neuralink, a US company specializing in brain-computer interfaces, has developed a fully implantable wireless system called N1 that is designed to capture brain signals and convert them into control commands for computers or other devices. According to the company, the system is aimed primarily at people with severe paralysis in order to give them more independence when operating digital devices. An early study is currently underway to test the safety and functionality of the implant.

Noble himself describes the implantation as surprisingly straightforward: he was placed under general anesthesia, after which 1,024 electrodes were inserted. According to German website Golem, he was discharged home the day after the procedure and felt significantly better by day three. The real everyday test began in week two, after the system had been paired with a MacBook and calibrated by Neuralink engineers. By week three, the controls already felt natural.

Particularly striking is Noble’s statement that on day 80 he launched World of Warcraft for the first time using thought control alone. The first raid still felt a little rough, but after that it was “pure magic.” He now says he can explore Azeroth hands-free and move through the game world at full speed. Golem highlights the same passage and describes the experience as “magical,” “ingenious,” and “addictive.”

Noble’s conclusion after 100 days is correspondingly euphoric. He wrote that he could hardly imagine life without the implant anymore. It had given him not only a new way to use computers, but a new way to live.

Noble’s account marks a remarkable moment in the public perception of brain-computer interfaces. Instead of simple cursor movements, a complex and popular MMORPG like World of Warcraft takes center stage. As a result, the technology no longer seems like an abstract laboratory project, but rather like a tangible everyday tool that could give people with disabilities more independence and greater digital participation. At the same time, however, it remains clear that Neuralink N1 is still in an early clinical phase and a long way from becoming a widely used everyday technology.